MDT · News · 20261012N

Reimbursement and Payer Mix

Medtronic plc · 2026-10-12 · Importance 40 · Surprise 42

Medtronic achieved 96% U.S. reimbursement coverage for its VenaSeal system, reducing a stated adoption barrier for the vein-treatment product. New CPT codes were issued for the Altaviva and Symplicity Spyral systems, supporting reimbursement for neuromodulation and renal-denervation procedures. The company also received FDA clearance for ApexCut EM blades and additional FDA and CE Mark approvals for cardiac-ablation technologies, expanding the reimbursed and commercially available product portfolio.

Key facts